Research boost to improve outcomes for patients
11 October 2017
More than $3.5 million in competitive funding grants have been awarded to researchers at Melanoma Institute Australia as part of the National Health and Medical Research Council’s (NHMRC) funding outcomes, announced today.
In partnership with The University of Sydney, the boost will support a Practitioner Fellowship, a Career Development Fellowship and a Centre of Research Excellence aimed at driving better outcomes in melanoma.
MIA’s Co-Medical Director, Professor Richard Scolyer, was awarded a Practitioner Fellowship that will aim to utilise the extensive resources at MIA to improve outcomes of patients with difficult and aggressive melanomas.
Epidemiologist Associate Professor Anne Cust received a Career Development Fellowship for her research into skin cancer epidemiology, prevention and screening that will lead to improved patient and population health through impacting clinical practice and health policy.
Chair of MIA’s Research Committee Professor Graham Mann was awarded the Centre of Research Excellence in Melanoma grant. The project will identify the best way to conduct surveillance of high-risk melanoma patients, how to manage a person with melanoma who has a high potential for relapse, and how best to improve support, survivorship and the patient experience.
The funding will help facilitate MIA’s world-leading researchers to continue their ground-breaking work in melanoma research in order to improve outcomes for patients and their families.
Sydney Health Partners' goal is to ensure world class research is successfully implemented & scaled-up to benefit patients & wider society.
Promising young MIA researcher conferred with University of Sydney PhD.
Jana Pittman and Melinda Gainsford-Taylor urge Australians to be sun-safe and check their skin as they join the Game On Mole campaign in support of their much-loved coach
Cited an incredible 427 times around the world, showing its vital role in improving outcomes for people with advanced melanoma.
Honouring the exceptional impact of his work on communities around the world.
MIA's Co-Medical Directors receive University of Sydney's Vice-Chancellor's Award for Outstanding Research
Awarded for their life-saving discoveries transforming melanoma patient care.
National day of action called amidst fears COVID lockdowns have deterred patients from seeking potentially life-saving medical treatment
Recognising her pioneering work in immunotherapy in melanoma, transforming the care of patients worldwide.
Clinicians and researchers from across Australia and beyond united online, bringing the AMC2021 conference theme of Promising Futures to life.
Melanoma Institute Australia is proud to announce that the Nine Network’s Peter Overton AM has joined us as a National Ambassador.
MIA is proud to announce that five of our researchers have been named on the Clarivate Annual Highly Cited Researchers™ 2021 list.
New research shows routine skin checks by a health professional, coupled with checking your own skin, are vital in saving lives from melanoma.
With new patient figures indicating people may have deferred skin checks during the pandemic our Game On Mole campaign is more important than ever.
We are excited to announce a return to our much-loved physical Melanoma March events in March 2022!
Read more about the wonderful MIA community fundraising initiatives held recently.
Drug therapy set to become standard treatment in high-risk early stage patients to stop disease spread
Over two fun, yet challenging, days in September an intrepid group of riders and crew successfully completed the annual Melanoma Bike Bash in WA!
Prof Long AO has been recognised by Australian Academy of Health and Medical Sciences for her transformative work advancing melanoma treatments.
Three MIA researchers at University of Sydney received grants to further their important melanoma research.
COVID restrictions continue to impact fundraising for melanoma services in Riverina.